blood clots

COVID-19

US to resume J&J COVID vaccinations despite rare clot risk

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J

COVID-19

Was Pulling the J &J Vaccine The Right Move? A Q &A With Dr. Megan Ranney

Dr. Megan Ranney is a practicing emergency physician, researcher, and advocate for innovative approaches to health. She is also the Associate Dean of Strategy and Innovation for the Brown University School of Public Health. She spoke to Michael Graham of InsideSources.com about the Biden administration’s decision to call a halt to the use of the

Scroll to Top